{
  "as_of": "2026-10-23",
  "state": "FL",
  "name": "Florida",
  "status": "not-covered",
  "statusLabel": "Not covered for obesity alone",
  "effective": "2026-07-02",
  "effectiveWhat": "criteria revised",
  "note": "GLP-1 criteria require type 2 diabetes; Wegovy, Zepbound and Saxenda are not on the drug list.",
  "source": {
    "title": "AHCA GLP-1 receptor agonist PA criteria, rev. 7/2/2026, and PDL eff. Oct 1, 2026",
    "url": "https://ahca.myflorida.com/file/medicaid/Drug%20Criteria/Glucagon-like_Peptide-1_(GLP-1)_Receptor_Agonist_10.01.2026.pdf"
  },
  "read": "2026-10-23",
  "url": "https://kymatahealth.com/telehealth/glp1-coverage-map",
  "page": "https://kymatahealth.com/telehealth/glp1-coverage-map/florida",
  "cite": "https://kymatahealth.com/telehealth/glp1-coverage-map/florida"
}